Ulrike Lorch

8PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesNanotoxicology, health and safetyFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 10, 2024
Randomized, placebo-controlled, double-blind phase I trial of co-administered pyronaridine and piperaquine in healthy adults of sub-Saharan origin.

Andrea Kuemmerle, Denis Gossen, Annick Janin

|Jun 02, 2021
Concentration-QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers.

Jӧrg Täubel, Ulrike Lorch, Georg Ferber

|Jan 12, 2020
First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection.

M Farouk Chughlay, Emilie Rossignol, Cristina Donini

|Mar 21, 2019
Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone.

Oliver Pohl, Line Marchand, Jean-Pierre Gotteland

|Jun 30, 2018
Pharmacokinetics of Tramadol and Celecoxib in Japanese and Caucasian Subjects Following Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label Study.

Helen Dooner, Gill Mundin, Sabine Mersmann

|Jun 10, 2018
A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition.

Valerie Cuvier, Ulrike Lorch, Stephan Witte

Pageof 2

Frequent Collaborators

2 joint publications

Mohamed Farouk Chughlay

1 joint publications

Marc Derive

1 joint publications

Carla Bennett

1 joint publications

Mercedes Encabo